Literature DB >> 3676819

Accumulation of circulating endogenous and exogenous immunoglobulins by hypothalamic magnocellular neurons.

M L Meeker1, R B Meeker, J N Hayward.   

Abstract

Rat monoclonal antibodies, used in immunocytochemistry of normal rat brain, result in a granular reaction product within neurons innervating areas lacking a blood-brain barrier. Immunocytochemical characterization shows that the staining is independent of the primary antibody and exclusively dependent on the presence of anti-rat immunoglobulin. This granular staining could be selectively eliminated by pre-adsorption of the anti-rat immunoglobulin with purified rat immunoglobulin or disruption of microtubule retrograde transport systems by intraventricular injection of colchicine. A dependence on retrograde transport and complete independence from local synthesis was further substantiated by the rapid uptake and accumulation of intravenously administered rabbit or rat [125I]immunoglobulins by the supraoptic-neurohypophysial system. Immunoelectron microscopy was used to identify the endogenous rat immunoglobulin within lysosome-like organelles in the cytoplasm of magnocellular neuroendocrine cells. The uptake and incorporation of plasma macromolecules into the lysosomal system of magnocellular and other neurons projecting to regions with a weak blood-brain barrier may represent a novel mode of blood-central nervous system interactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3676819     DOI: 10.1016/0006-8993(87)90823-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Pargyline conjugate-induced long-term activation of monoamine oxidase as an immunological model for depression.

Authors:  R A Danilova; T A Moskvityna; M F Obukhova; M V Belopolskaya; I P Ashmarin
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

2.  The effects of immunization against cholecystokinin fragment 30-33 in the behavior of white rats.

Authors:  R A Danilova; O I Rud'ko; T M Korotkova; M F Obukhova; I P Ashmarin
Journal:  Neurosci Behav Physiol       Date:  2002 Mar-Apr

Review 3.  Tau-focused immunotherapy for Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  Curr Alzheimer Res       Date:  2009-10       Impact factor: 3.498

4.  Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.

Authors:  Allal Boutajangout; Johanna Ingadottir; Peter Davies; Einar M Sigurdsson
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

5.  Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model.

Authors:  Allal Boutajangout; David Quartermain; Einar M Sigurdsson
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

Review 6.  Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies.

Authors:  Einar M Sigurdsson
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

7.  Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model.

Authors:  Pavan K Krishnamurthy; Yan Deng; Einar M Sigurdsson
Journal:  Front Psychiatry       Date:  2011-10-21       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.